Company profile

Gedea Biotech company profile

Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections. Vaginal yeast infections are a major problem that affects about 75% of all women at some point in life. Gedea Biotech's substance, GA101, is a natural substance that has always been part of their environment. It acts by lowering the pH as well as providing a physical barrier protection and inhibiting biofilm formation. The first product will be a topical treatment of vaginal fungal infections.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2015-01-01

Headquarters

Headquarters
Lund, Skane Lan, Sweden
Country code
SE
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
9
Total equity funding
$4.2M
Last funding
Grant / $2.7M / 2024-02-29
Last equity funding
Series Unknown / $1.6M
Investors
9
Lead investors
4
Founders
4
Articles
16

Founders and investors

Founders

Helena StrevensOlov SternerSophie MannerUlf Ellervik

Lead investors

Almi InvestEIC AcceleratorPorte MonnaieSmiLe Incubator

Investors

Almi InvestEIC AcceleratorEISMEALU InnovationSmiLe Incubator

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.